The future of tyrosin kinase inhibitors
Symposium Chairs: Rudolf M. Huber (München, Germany), Thierry Berghmans (Brussels, Belgium)
Aims: To describe the present and forthcoming tyrosine kinase inhibitors (TKIs) and their indications as well as to portray future developments up-to-the-minute.